Short-term effects of lithium on white blood cell counts and on levels of serum thyroid-stimulating hormone and creatinine in adolescent inpatients: A retrospective naturalistic study

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 9, 2014, Pages 494-500

  Amitai, Maya ^a,b   Zivony, Amir ^b   Kronenberg, Sefi ^a,b,c   Nagar, Liron ^a,b   Saar, Sivan ^a,b   Sever, Jonathan ^a,b   Apter, Alan ^b,c   Shoval, Gal ^a,b   Golubchik, Pavel ^a,b   Hermesh, Haggai ^a,b   Weizman, Abraham ^a,b   Zalsman, Gil ^a,b,d  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CREATININE; HALOPERIDOL; LAMOTRIGINE; LEVOMEPROMAZINE; LEVOTHYROXINE; LITHIUM; METHYLPHENIDATE; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; THYROTROPIN; VALPROIC ACID; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ELECTRONIC MEDICAL RECORD; EVENING DOSAGE; FEMALE; HEMATOLOGICAL PARAMETERS; HOSPITALIZATION; HUMAN; HYPOPHYSIS THYROID SYSTEM; KIDNEY FUNCTION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; PATIENT MONITORING; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; BLOOD; DRUG EFFECTS; MENTAL DISORDERS; THYROID GLAND;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CHILD; CREATININE; FEMALE; HUMANS; LEUKOCYTE COUNT; LITHIUM; MALE; MENTAL DISORDERS; RETROSPECTIVE STUDIES; THYROID GLAND; THYROTROPIN;

EID: 84911472213     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0046     Document Type: Article

References (31)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994.
2. Barbesino G: Drugs affecting thyroid function. Thyroid 20:763-770, 2010.
3. Bocchetta A, Loviselli A: Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health 2:23, 2006.
4. Cade JF: Lithium salts in the treatment of psychotic excitement. 1949. Bull World Health Organ 78:518-520, 2000.
5. Chakrabarti S: Thyroid functions and bipolar affective disorder. J Thyroid Res 2011:306-367, 2011.
6. Correll CU, Carlson HE: Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 45:771-791, 2006.
7. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, Kowatch R, Rowles BM, Clemons TE, Taylor-Zapata P: Post-acute effectiveness of lithium in pediatric bipolar I disorder. J Child Adolesc Psychopharmacol 23:80-90, 2013.
8. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Rowles BM, Clemons TE, Taylor-Zapata P: Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 21:195-205, 2011.
9. Gelenberg AJ, Wojcik JD, Falk WE, Coggins CH, Brotman AW, Rosenbaum JF, LaBrie RA, Kerman BJ: Effects of lithium on the kidney. Acta Psychiatr Scand 75:29-34, 1987.
10. Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P: A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 69:515-528, 2012.
11. Goodwin FK: Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 63 (Suppl 10):5-12, 2002.
12. Gracious BL, Findling RL, Seman C, Youngstrom EA, Demeter CA, Calabrese JR: Elevated thyrotropin in bipolar youths prescribed both lithium and divalproex sodium. J Am Acad Child Adolesc Psychiatry 43:215-220, 2004.
13. Johnston AM, Eagles JM: Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 175:336-339, 1999.
14. Kafantaris V, Coletti D, Dicker R, Padula G, Kane JM: Lithium treatment of acute mania in adolescents: A large open trial. J Am Acad Child Adolesc Psychiatry 42:1038-1045, 2003.
15. Kafantaris V, Coletti DJ, Dicker R, Padula G, Pleak RR, Alvir JM: Lithium treatment of acute mania in adolescents: A placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 43:984-993, 2004.
16. Kleiner J, Altshuler L, Hendrick V, Hershman JM: Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry 60:249-255, 1999.
17. Lazarus JH: Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 23:723-733, 2009.
18. Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M: Renal insufficiency in long-term lithium treatment. J Clin Psychiatry 65:850-856, 2004.
19. McCann SM, Daly J, Kelly CB: The impact of long-term lithium treatment on renal function in an outpatient population. Ulster Med J 77:102-105, 2008.
20. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR: Lithium toxicity profile: A systematic review and meta-analysis. Lancet 379:721-728, 2012.
21. Oyesanmi O, Kunkel EJ, Monti DA, Field HL: Hematologic side effects of psychotropics. Psychosomatics 40:414-421, 1999.
22. Ozdemir MA, Sofuoglu S, Tanrikulu G, Aldanmaz F, Esel E, Dundar S: Lithium-induced hematologic changes in patients with bipolar affective disorder. Biol Psychiatry 35:210-213, 1994.
23. Paul R, Minay J, Cardwell C, Fogarty D, Kelly C. Meta-analysis of the effects of lithium usage on serum creatinine levels. J Psychopharmacol 24:1425-1431, 2010.
24. Pavuluri MN, Henry DB, Carbray JA, Sampson GA, Naylor MW, Janicak PG: A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. J Child Adolesc Psychopharmacol 16:336-350, 2006.
25. Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG: Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 82 (Suppl 1):S103-S111, 2004.
26. Thomas T, Stansifer L, Findling RL: Psychopharmacology of pediatric bipolar disorders in children and adolescents. Pediatr Clin North Am 58:173-87, xii, 2011.
27. Transbol I, Christiansen C, Baastrup PC: Endocrine effects of lithium. I. Hypothyroidism, its prevalence in long-term treated patients. Acta Endocrinol (Copenh) 87:759-767, 1978.
28. Tredget J, Kirov A, Kirov G: Effects of chronic lithium treatment on renal function. J Affect Disord 126:436-440, 2010.
29. Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Kitagawa T: Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol 15:694-699, 2011.
30. Vitiello B: Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics 108:983-989, 2001.
31. Zhang ZJ, Li Q, Kang WH, Tan QR, Gao CG, Zhang FG, Wang HH, Ma XC, Chen C, Wang W, Guo L, Zhang YH, Yang XB, Zhang RG: Differences in hypothyroidism between lithium-free and -treated patients with bipolar disorders. Life Sci 78:771-776, 2006.